Skip to main content
Top
Published in: Clinical Rheumatology 3/2004

01-06-2004 | Case Report

Successful treatment of fulminant pulmonary hemorrhage associated with systemic lupus erythematosus

Authors: Ken-ichi Hoshi, Masayuki Matsuda, Mariko Ishikawa, Shigeaki Mitsuhashi, Takahisa Gono, Takao Hashimoto, Shu-ichi Ikeda

Published in: Clinical Rheumatology | Issue 3/2004

Login to get access

Abstract

We report a patient with systemic lupus erythematosus (SLE) who developed fulminant pulmonary hemorrhage. This patient also showed liver dysfunction, bicytopenia and hyperferritinemia, with an increase in serum levels of interleukin (IL)-1β, IL-6 and tumor necrosis factor-α (TNF-α) at the onset of pulmonary symptoms, probably indicating an associated hemophagocytic syndrome. Despite an acute progressive course temporarily requiring mechanical ventilation the patient was successfully treated with continuous drip infusion of tacrolimus, plasmapheresis and intravenous high-dose immunoglobulin and corticosteroid. In this patient increased inflammatory cytokines ascribable to activation of macrophages and/or helper T cells were considered to play an important role in the pathogenesis of the pulmonary hemorrhage. Because this complication is frequently fatal in SLE, intensive therapy, including immunosuppressants and plasmapheresis, should be actively considered as early as possible after onset.
Literature
1.
go back to reference D’Cruz D, Khamashta M, Hughes G (2002) Pulmonary manifestations of systemic lupus erythematosus. In: DJ Wallace et al (eds) Dubois’ lupus erythematosus, 6th edn. Lippincott Williams & Wilkins, Philadelphia, pp 663–683 D’Cruz D, Khamashta M, Hughes G (2002) Pulmonary manifestations of systemic lupus erythematosus. In: DJ Wallace et al (eds) Dubois’ lupus erythematosus, 6th edn. Lippincott Williams & Wilkins, Philadelphia, pp 663–683
2.
go back to reference Domingo-Pedrol P, Rodriguez de la Serna A, Mancebo-Cortes J, Sanchez-Segura JM (1985) Adult respiratory distress syndrome caused by acute systemic lupus erythematosus. Eur J Respir Dis 67:141–144PubMed Domingo-Pedrol P, Rodriguez de la Serna A, Mancebo-Cortes J, Sanchez-Segura JM (1985) Adult respiratory distress syndrome caused by acute systemic lupus erythematosus. Eur J Respir Dis 67:141–144PubMed
3.
go back to reference Asherson RA, Ridley M, Fletcher CD, Hughes GR (1988) Systemic lupus erythematosus, pulmonary hypertension and adult respiratory distress syndrome (ARDS). Clin Exp Rheumatol 6:301–304PubMed Asherson RA, Ridley M, Fletcher CD, Hughes GR (1988) Systemic lupus erythematosus, pulmonary hypertension and adult respiratory distress syndrome (ARDS). Clin Exp Rheumatol 6:301–304PubMed
4.
go back to reference Kim WU, Kim SI, Yoo WH et al. (1999) Adult respiratory distress syndrome in systemic lupus erythematosus: causes and prognostic factors: a single center, retrospective study. Lupus 8:552–557CrossRefPubMed Kim WU, Kim SI, Yoo WH et al. (1999) Adult respiratory distress syndrome in systemic lupus erythematosus: causes and prognostic factors: a single center, retrospective study. Lupus 8:552–557CrossRefPubMed
5.
go back to reference Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725 Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725
6.
go back to reference Hallegua DS, Wallace DJ (2002) Gastrointestinal and hepatic manifestations. In: DJ Wallace et al (eds) Dubois’ lupus erythematosus, 6th edn. Lippincott Williams & Wilkins, Philadelphia, pp 843–861 Hallegua DS, Wallace DJ (2002) Gastrointestinal and hepatic manifestations. In: DJ Wallace et al (eds) Dubois’ lupus erythematosus, 6th edn. Lippincott Williams & Wilkins, Philadelphia, pp 843–861
7.
go back to reference Henter J-I, Elinder G, Öst Å (1999) Diagnostic guidelines for hemophagocytic lymphohistiocytosis. Semin Oncol 18:29–33 Henter J-I, Elinder G, Öst Å (1999) Diagnostic guidelines for hemophagocytic lymphohistiocytosis. Semin Oncol 18:29–33
9.
go back to reference Green RJ, Ruoss SJ, Kraft SA, Duncan SR, Berry GJ, Raffin TA (1996) Pulmonary capillaritis and alveolar hemorrhage. Update on diagnosis and management. Chest 110:1305–1316PubMed Green RJ, Ruoss SJ, Kraft SA, Duncan SR, Berry GJ, Raffin TA (1996) Pulmonary capillaritis and alveolar hemorrhage. Update on diagnosis and management. Chest 110:1305–1316PubMed
10.
go back to reference Jara LJ, Vera-Lastra O, Calleja MC (2003) Pulmonary-renal vasculitic disorders: differential diagnosis and management. Curr Rheumatol Rep 5:107–115PubMed Jara LJ, Vera-Lastra O, Calleja MC (2003) Pulmonary-renal vasculitic disorders: differential diagnosis and management. Curr Rheumatol Rep 5:107–115PubMed
11.
go back to reference Lauqua D, Cadranel J, Lazor R et al. (2000) Microscopic polyangiitis with alveolar hemorrhage. A study of 29 cases and review of the literature. Medicine (Baltimore) 79:222–233 Lauqua D, Cadranel J, Lazor R et al. (2000) Microscopic polyangiitis with alveolar hemorrhage. A study of 29 cases and review of the literature. Medicine (Baltimore) 79:222–233
12.
go back to reference Eagen JW, Memoli VA, Roberts JL, Matthew GR, Schwartz MM, Lewis EJ (1978) Pulmonary hemorrhage in systemic lupus erythematosus. Medicine (Baltimore) 57:545–560 Eagen JW, Memoli VA, Roberts JL, Matthew GR, Schwartz MM, Lewis EJ (1978) Pulmonary hemorrhage in systemic lupus erythematosus. Medicine (Baltimore) 57:545–560
13.
go back to reference Moss M, Ingram RH Jr (2001) Acute respiratory distress syndrome. In: E Braunwald et al. (eds) Harrison’s principles of internal medicine, 15th edn. McGraw-Hill, New York, pp 1523–1526 Moss M, Ingram RH Jr (2001) Acute respiratory distress syndrome. In: E Braunwald et al. (eds) Harrison’s principles of internal medicine, 15th edn. McGraw-Hill, New York, pp 1523–1526
14.
go back to reference Lewis EJ, Hunsicker LG, Lan SP, Rohde RD, Lachin JM (1992) A controlled trial of plasmapheresis therapy in severe lupus nephritis. N Engl J Med 326:1373–1379PubMed Lewis EJ, Hunsicker LG, Lan SP, Rohde RD, Lachin JM (1992) A controlled trial of plasmapheresis therapy in severe lupus nephritis. N Engl J Med 326:1373–1379PubMed
15.
go back to reference Erickson RW, Franklin WA, Emlen W (1994) Treatment of hemorrhagic lupus pneumonitis with plasmapheresis. Semin Arthritis Rheum 24:114–123PubMed Erickson RW, Franklin WA, Emlen W (1994) Treatment of hemorrhagic lupus pneumonitis with plasmapheresis. Semin Arthritis Rheum 24:114–123PubMed
16.
go back to reference Dalakas MC (1998) Mechanism of action of intravenous immunoglobulin and therapeutic considerations in the treatment of autoimmune neurologic diseases. Neurology 51(Suppl): S2–8 Dalakas MC (1998) Mechanism of action of intravenous immunoglobulin and therapeutic considerations in the treatment of autoimmune neurologic diseases. Neurology 51(Suppl): S2–8
17.
go back to reference Kilian K, Banyai A, Karadi A, Miklos K, Patranyi GG, Paloczi K (1998) FK-506 (tacrolimus) therapy for an unusual SLE-like disease. Transplant Proc 30:4130–4131CrossRefPubMed Kilian K, Banyai A, Karadi A, Miklos K, Patranyi GG, Paloczi K (1998) FK-506 (tacrolimus) therapy for an unusual SLE-like disease. Transplant Proc 30:4130–4131CrossRefPubMed
18.
19.
go back to reference Manger K, Kalden JR, Manger B (1996) Cyclosporin A in the treatment of systemic lupus erythematosus: results of an open clinical study. Br J Rheumatol 35:669–675PubMed Manger K, Kalden JR, Manger B (1996) Cyclosporin A in the treatment of systemic lupus erythematosus: results of an open clinical study. Br J Rheumatol 35:669–675PubMed
20.
go back to reference Schreiber SL, Crabtree GR (1992) The mechanism of action of cyclosporin A and FK506. Immunol Today 13:136–142PubMed Schreiber SL, Crabtree GR (1992) The mechanism of action of cyclosporin A and FK506. Immunol Today 13:136–142PubMed
21.
go back to reference Moon JI, Park SG, Cheon KO (2000) Pregnancy in renal transplant patients. Transplant Proc 32:1869–1870CrossRefPubMed Moon JI, Park SG, Cheon KO (2000) Pregnancy in renal transplant patients. Transplant Proc 32:1869–1870CrossRefPubMed
22.
go back to reference Yasuhara M, Hashida T, Toraguchi M et al. (1995) Pharmacokinetics and pharmacodynamics of FK506 in pediatric patients receiving living-related donor liver transplantation. Transplantation Proc 27:1108–1110 Yasuhara M, Hashida T, Toraguchi M et al. (1995) Pharmacokinetics and pharmacodynamics of FK506 in pediatric patients receiving living-related donor liver transplantation. Transplantation Proc 27:1108–1110
Metadata
Title
Successful treatment of fulminant pulmonary hemorrhage associated with systemic lupus erythematosus
Authors
Ken-ichi Hoshi
Masayuki Matsuda
Mariko Ishikawa
Shigeaki Mitsuhashi
Takahisa Gono
Takao Hashimoto
Shu-ichi Ikeda
Publication date
01-06-2004
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 3/2004
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-003-0859-2

Other articles of this Issue 3/2004

Clinical Rheumatology 3/2004 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine